Clinical Trial Update: A Clinical Study to Evaluate The Safety and Effectiveness of The RxSight Light Adjustable Lens (LAL) In Subjects Desiring an Extended Depth of Focus

View source ↗

Summary

This clinical trial update reports on a terminated study evaluating the safety and effectiveness of the RxSight Light Adjustable Lens (LAL) in subjects seeking …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aphakia
• Cataract
• Presbyopia

Snippet

Sponsor: RxSight, Inc. | Conditions: Aphakia, Cataract | Status: TERMINATED | Results posted: 2025-01-07